AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Each Tablet Contains: Metformin Hydrochloride 500,0 Mg

9 registrations across 1 African market— 9 active

Markets with Each Tablet Contains: Metformin Hydrochloride 500,0 Mg

Recent registrations

Brand / ProductMarketHolderStatusExpires
EACH 1,0 g SPRAY SOLUTION CONTAINS: CLOBETASOL PROPIONATE 500,0 μg🇿🇦South AfricaUnimed Healthcare (Pty) LtdactiveMay 2031
METRYXA 500 mg XR🇿🇦South AfricaUnimed Healthcare (Pty) LtdactiveMay 2031
METFORMIN 500 mg XR PD🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveFeb 2031
GLIFAGE XR 500 mg🇿🇦South AfricaMerck (Pty) LtdactiveDec 2030
RISIDON XR 500mg🇿🇦South AfricaMerck (Pty) LtdactiveDec 2030
GLAFORNIL XR 500 mg🇿🇦South AfricaMerck (Pty) LtdactiveDec 2030
DIAMET XR 500🇿🇦South AfricaInnovata PharmaceuticalsactiveJun 2030
MACLOGLYMIN 500 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
METORED 500🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJan 1900

Each Tablet Contains: Metformin Hydrochloride 500,0 Mg in Africa — Regulatory Overview

Each Tablet Contains: Metformin Hydrochloride 500,0 Mg is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.